ACYLTHIOL AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI- RETROVIRAL AGENTS Read more about ACYLTHIOL AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI- RETROVIRAL AGENTS Patent Cooperation TreatyPCT/US2002/023924Filed on 2002-07-25
HEPATITIS A VIRUS VACCINES Read more about HEPATITIS A VIRUS VACCINES US Patent 6,680,060Filed on 2002-04-29
BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS Read more about BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS US Patent 6,962,987Filed on 2002-05-21
METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING CHOLERA TOXIN B SUBUNIT Read more about METHODS OF TREATING INFLAMMATORY BOWEL DISEASE USING CHOLERA TOXIN B SUBUNIT US Patent 7,041,296Filed on 2002-09-17
Production of Attenuated Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines Read more about Production of Attenuated Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines US Application 10/031,095Filed on 2002-01-09
ATTENUATED HUMAN ROTAVIRUS VACCINE Read more about ATTENUATED HUMAN ROTAVIRUS VACCINE Patent Cooperation TreatyPCT/US95/008665Filed on 1995-07-11
Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Read more about Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Patent Cooperation TreatyPCT/US2002/016308Filed on 2002-05-22
Recombinant ORF2 Proteins of the Swine Hepatitis E Virus and Their Use as A Vaccine and as a Diagnostic Reagent for Medical and Vetinirary Applications Read more about Recombinant ORF2 Proteins of the Swine Hepatitis E Virus and Their Use as A Vaccine and as a Diagnostic Reagent for Medical and Vetinirary Applications Patent Cooperation TreatyPCT/US02/14100Filed on 2002-05-02
Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof Read more about Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof Patent Cooperation TreatyPCT/US02/19663Filed on 2002-06-18
Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors US Patent 7,468,352Filed on 2002-03-22